Myocardial Infarction Revision Infographic

Overview:
A myocardial infarction (MI), commonly called a heart attack, is death of heart muscle caused by an inadequate blood supply. It most often occurs when an atherosclerotic plaque in a coronary artery ruptures and a blood clot forms, restricting or stopping blood flow to part of the myocardium. Because prolonged oxygen deprivation causes irreversible damage, MI is a medical emergency: early recognition and treatment can limit heart-muscle loss and improve outcomes. Suspected heart attack requires an immediate call to 999.

MI is part of the wider spectrum of acute coronary syndromes, which also includes unstable angina. Symptoms commonly include central chest pressure or tightness, breathlessness, sweating and nausea, but presentation can be less typical, particularly in older people, women and people with diabetes. Diagnosis uses the clinical picture alongside a 12-lead ECG and blood tests, especially serial high-sensitivity troponin measurements. Treatment aims to restore coronary blood flow when indicated, prevent further clot formation, manage symptoms and complications, and reduce the risk of another event.

Key Concepts & Definitions:
• Myocardial infarction (MI): Death of heart muscle cells caused by prolonged inadequate blood supply, usually due to a blocked coronary artery. The affected area is described as infarcted or necrotic myocardium.
• Coronary arteries: Blood vessels that supply oxygenated blood to the heart muscle. Narrowing or blockage can deprive the myocardium of oxygen.
• Myocardial ischaemia: A mismatch between the heart muscle’s oxygen supply and its demand. Ischaemia may be reversible if blood flow is restored before cells die.
• Atherosclerosis: A disease in which fatty and inflammatory material builds up within artery walls, forming plaques. Plaques can narrow arteries and may rupture, triggering clot formation.
• Plaque rupture: A break in the surface of an atherosclerotic plaque that exposes material capable of activating clotting. This can lead to a rapid reduction or cessation of blood flow.
• Thrombus: A blood clot formed within a blood vessel. In a coronary artery, a thrombus can partly or completely obstruct blood flow to the myocardium.
• Acute coronary syndrome (ACS): A group of urgent conditions caused by sudden reduced blood flow to the heart, including STEMI, NSTEMI and unstable angina. Assessment and early treatment are time-critical.
• STEMI: An MI with characteristic ST-segment elevation on the ECG in the relevant clinical context. It usually indicates acute coronary occlusion and requires urgent assessment for reperfusion treatment.
• NSTEMI: An MI without the defining ST-segment elevation pattern, often with other ECG changes and a rise or fall in troponin. Absence of ST elevation does not mean the event is harmless or that the artery is not seriously narrowed.
• Unstable angina: Acute coronary ischaemia without evidence of heart-muscle cell death on troponin testing. It is still an emergency and forms part of the ACS spectrum.
• Troponin: A protein released into the blood when heart-muscle cells are damaged. A rise or fall in high-sensitivity troponin, interpreted with symptoms and other findings, supports a diagnosis of MI.
• 12-lead ECG: A recording of the heart’s electrical activity from multiple viewpoints. It can identify ST elevation and other changes, but a normal initial ECG does not by itself rule out MI.
• Typical symptoms: Chest pressure, tightness or discomfort, sometimes radiating to the arm, jaw, neck, back or other areas. Breathlessness, sweating, nausea and vomiting may occur as well.
• Atypical presentation: MI may occur without prominent chest pain, with symptoms such as breathlessness, fatigue, confusion or nausea. Atypical symptoms are especially important to consider in older people, women and people with diabetes.
• Risk factors: Factors associated with greater likelihood of coronary artery disease include smoking, hypertension, high cholesterol, diabetes, increasing age, obesity, inactivity and family history. Risk factors raise probability but do not establish a diagnosis.
• Reperfusion: Treatment to restore blood flow through a blocked coronary artery. Primary percutaneous coronary intervention (PCI) is generally preferred for STEMI when it can be delivered in an appropriate timeframe; other options depend on clinical circumstances and local pathways.
• PCI: A procedure in which a catheter is used to treat a narrowed or blocked coronary artery, commonly by balloon angioplasty and stent placement. It is used as a reperfusion strategy, particularly for STEMI.
• Antiplatelet treatment: Medicines such as aspirin and a P2Y12 inhibitor reduce platelet activation and clot growth. Dual antiplatelet therapy (DAPT) means using two antiplatelet medicines together when clinically prescribed.
• Anticoagulant treatment: Medicines that reduce blood coagulation and help prevent further thrombus formation or extension. The specific medicine and dose are selected by clinicians according to the situation and protocol.
• Oxygen: Supplemental oxygen is used when a patient is hypoxaemic or otherwise meets clinical criteria, rather than routinely for every suspected MI. Oxygen targets should take account of the patient’s condition and any risk of carbon-dioxide retention.
• Nitrates: Glyceryl trinitrate (GTN) can relieve ischaemic chest discomfort by reducing cardiac workload, but it is not suitable for everyone. Blood pressure, possible right-ventricular involvement and recent use of medicines such as PDE5 inhibitors must be considered by clinicians.
• Analgesia and antiemetics: Pain relief and treatment for nausea may be provided as part of acute care. Choice of medicine depends on the patient and clinical assessment; these treatments do not replace reperfusion or other essential care.
• Complications: MI can lead to arrhythmias, heart failure, cardiogenic shock and mechanical complications such as rupture of heart structures. Risk depends on the size and location of the infarct and the patient’s condition.
• Secondary prevention: Measures after an MI aim to reduce future cardiovascular events and support recovery. They can include prescribed medicines, smoking cessation, risk-factor management and cardiac rehabilitation.
• Cardiac rehabilitation: A structured programme supporting recovery through supervised activity, education and help with lifestyle and psychological needs. It forms an important part of ongoing care after MI.

Detailed Analysis:
The usual sequence begins with coronary atherosclerosis. Over time, plaques can form in the artery wall; if a plaque becomes unstable and ruptures, platelets are activated and the clotting system produces a thrombus. The resulting obstruction reduces oxygen delivery to the heart muscle. If the imbalance between oxygen supply and demand persists, myocardial cells become irreversibly damaged and die. The urgency of treatment follows from this progression: the longer severe ischaemia continues, the greater the potential area of injury.

The type of ACS is determined through clinical assessment, ECG findings and blood tests rather than symptoms alone. ST-segment elevation on an ECG in the appropriate context can indicate STEMI and prompts urgent evaluation for reperfusion. NSTEMI involves myocardial injury, typically supported by a rise or fall in troponin, but lacks the defining ST-elevation pattern. Unstable angina causes acute ischaemia without detectable myocardial cell death by troponin testing. ECGs and troponin results must be interpreted in context, and repeat testing may be needed because early results can be inconclusive.

Initial care combines rapid assessment with monitoring and preparation for definitive treatment. Clinicians assess airway, breathing and circulation, record observations, obtain a 12-lead ECG, establish access for treatment where appropriate, and take blood tests including troponin. Continuous cardiac monitoring helps identify dangerous rhythm disturbances. Oxygen is given when indicated by hypoxaemia or clinical criteria, not automatically to every patient. Medicines such as aspirin, other antiplatelet agents, anticoagulants, GTN and analgesia may be used according to the diagnosis, contraindications and local protocol; none should delay urgent emergency assessment or reperfusion when indicated.

Restoring blood flow is central to management of STEMI. Primary PCI is generally the preferred reperfusion approach when it is available within the relevant clinical timeframe. If it cannot be provided appropriately, clinicians may consider an alternative such as thrombolysis for eligible patients, following current guidance and checking for contraindications. The choice is time-sensitive and depends on factors including symptom timing, access to PCI and bleeding risk. NSTEMI management is also urgent, but the timing and type of invasive treatment are guided by risk assessment and clinical findings rather than applying the STEMI pathway automatically.

Treatment also addresses the consequences of ischaemia and protects the heart from further damage. MI can trigger arrhythmias, weaken the left ventricle and cause heart failure or cardiogenic shock; less commonly, structural damage can cause complications such as papillary muscle or septal rupture. Echocardiography can assess heart structure and pumping function, while coronary angiography helps visualise coronary arteries and guide treatment. Chest X-ray may help investigate alternative diagnoses or complications, but it does not confirm MI. Prompt recognition of deterioration and appropriate escalation are essential.

After the acute event, secondary prevention aims to lower the chance of recurrent MI and support long-term health. Depending on the individual, clinicians may prescribe antiplatelet therapy, a statin and other medicines such as a beta-blocker or ACE inhibitor, taking account of indications, contraindications and current guidance. Risk-factor management includes stopping smoking, controlling blood pressure and cholesterol, managing diabetes, improving diet and becoming physically active when safe. Cardiac rehabilitation, follow-up and psychological support can help people recover and sustain these changes.

Exam Focus & Common Mistakes:
In an exam, distinguish STEMI, NSTEMI and unstable angina by combining ECG evidence with troponin and the presence or absence of myocardial injury; do not classify a case from symptoms alone. State that suspected MI is an emergency and that a 12-lead ECG and troponin testing are key investigations, while recognising that one normal ECG or an early negative troponin does not necessarily exclude MI. For STEMI, identify urgent reperfusion assessment and explain why PCI is generally preferred when timely and available.

Avoid saying that oxygen, GTN or morphine is appropriate for every patient: oxygen depends on hypoxaemia or clinical criteria, and medicines have contraindications. Do not confuse antiplatelets, which reduce platelet activation, with anticoagulants, which act on the coagulation system. Explain the purpose of treatment as well as naming it, and do not present doses or treatment sequences as universal rules; follow the clinical scenario and current local guidance. When discussing risk factors, distinguish modifiable factors such as smoking and hypertension from non-modifiable factors such as age and family history.

Linked Ideas:
MI links cardiovascular risk factors to atherosclerosis, thrombosis and tissue injury. It also illustrates the general relationship between oxygen supply and demand: when coronary blood flow cannot meet the myocardium’s needs, ischaemia develops and may progress to cell death. ECG interpretation, biomarkers and clinical assessment work together because each provides different evidence about electrical changes, heart-muscle injury and the patient’s overall condition.

The acute and long-term phases of care are connected. Reperfusion and monitoring address immediate danger, while antithrombotic treatment and risk-factor management aim to prevent further events; rehabilitation supports physical and psychological recovery. MI can also cause heart failure and arrhythmias, linking acute coronary disease to longer-term management of cardiac function and rhythm.

Revision Approach:
Revise the topic as a sequence: risk factors and plaque formation, rupture and thrombosis, ischaemia and infarction, symptoms and investigations, acute treatment, complications, then secondary prevention. Make a comparison table for STEMI, NSTEMI and unstable angina, including ECG and troponin features, and practise explaining why each key intervention is used and when it may be unsuitable. Use scenario questions to practise recognising atypical symptoms, interpreting combined evidence and prioritising emergency action; check drug doses and detailed treatment pathways against your course specification and current guidance.

Final Takeaway:
A myocardial infarction is heart-muscle death caused by inadequate coronary blood flow, most often after plaque rupture and clot formation. Recognising possible MI quickly, using ECG and troponin appropriately, arranging the right urgent treatment and preventing future cardiovascular events are all essential parts of care.